Back
Monte Rosa Therapeutics Vs. Oklo Industry Stock Comparison
Sell
15
GLUE
Monte Rosa Therapeutics
Last Price:
$6.53
Seasonality Move:
0.27%
Buy
60
OKLO
Oklo
Last Price:
$29.50
Seasonality Move:
5.58%
Sell
15
Monte Rosa Therapeutics (GLUE)
is a Sell
Is Monte Rosa Therapeutics a Buy, Sell or Hold?
-
The current Monte Rosa Therapeutics [GLUE] share price is $6.53. The Score for GLUE is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
-
GLUE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
GLUE Stock Price Chart
What is Monte Rosa Therapeutics's stock price today?
-
The Monte Rosa Therapeutics share price today is $6.53Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GLUE is experiencing slight selling pressure.
OKLO Stock Price Chart
GLUE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.41 | Sell |
Relative Strength Index (14 RSI): | 37.21 | Sell |
Chaikin Money Flow: | -1095060 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
OKLO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.45 | Buy |
Relative Strength Index (14 RSI): | 69.14 | Buy |
Chaikin Money Flow: | 6972456 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
GLUE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.99 | Sell |
20-day SMA: | 7.47 | Sell |
50-day SMA: | 8.31 | Sell |
200-day SMA: | 5.95 | Buy |
8-day EMA: | 6.96 | Sell |
20-day EMA: | 7.39 | Sell |
50-day EMA: | 7.56 | Sell |
200-day EMA: | 6.43 | Buy |
OKLO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.3 | Buy |
20-day SMA: | 21.57 | Buy |
50-day SMA: | 21.96 | Buy |
200-day SMA: | 12.88 | Buy |
8-day EMA: | 24.72 | Buy |
20-day EMA: | 22.77 | Buy |
50-day EMA: | 20.57 | Buy |
200-day EMA: | 14.59 | Buy |
Monte Rosa Therapeutics Earnings Growth & GLUE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.48 per share, and a decrease next year of $0.24 per share.
Oklo Earnings Growth & OKLO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.27 per share, and a decrease next year of $0.06 per share.
Monte Rosa Therapeutics Technical Analysis
Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Oklo Technical Analysis
Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | Jan 6 | Jan 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | 06 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |